Across TCGA pan-cancer cohorts, RHOXF2B RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RHOXF2B’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where RHOXF2B RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RHOXF2B is over-expressed in tumor.

KICH and LIHC are the cancer types where RHOXF2B tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RHOXF2B RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	All	+0.187	.026	2	view →
LIHC	Female	All	+0.023	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RHOXF2B RNA expression & survival · all RHOXF2B data types